(PharmaNewsWire.Com, December 22, 2017 ) The OTC drugs market in Middle East and Africa has been estimated at USD 4,448.4 Million in 2016 and is projected to reach USD 6,689.7 Million by 2022, at a CAGR of 6.88% during the forecast period from 2016 to 2022. Over the counter(OTC) drugs are the safe and effective drugs, which can be bought at the pharmacies and local stores, over the counter, without doctors prescription. These drugs are used for common ailments. Easy accessibility, low cost, convenience, customer-empowering qualities are the benefits of OTC drugs.
The healthcare situation in Africa is bettering up with many foreign collaborators joining the African nations. Along with that, public are also resorting to lower-priced alternatives due to raising costs in healthcare. Due to the low per-capita income in majority of the countries in Africa, the OTC drugs are introduced to people at lower costs, thus, trying to expand the consumer base. These are some of the drivers that shoot up the market growth. However, the market growth is badly hindered due to the issue of drug substance abuse and lack of awareness in under-developed areas.
The African market is segmented based on product and geographically. The product market basically caters medicines in the categories like analgesics, cough, cold and flu products, dermatological products, gastrointestinal products, vitamins, minerals, weight loss products, sleep aids, ophthalmic products, smoking cession aids and other products.
Africa is a newly emerging market in the field of OTC drugs, as most of the African nations are under-developed. Amongst the developing countries, South Africa is said to be the leading contributor to the African market. The major problem prevailing in the African market is drug substance abuse. Codeine used in Broncleer cough syrup is banned in South Africa, as it is considered to be the most abused OTC drug.
Middle-East and Africa Over the Counter (OTC) Drugs Market Leaders' Analysis GlaxoSmithKline Johnson and Johnson Novartis Bayer Pfizer BoehringerIngelheim Sanofi Takeda PGT Healthcare
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
